We know NIV works well for patients with acute COPD or acute CHF exacerbations. In this episode we discuss the evidence for NIV not only in COPD and CHF, but also a myriad of other conditions. Do you know what the latest guidelines say on NIV for asthma, immunocompromised patients, or undifferentiated acute respiratory failure? Take a listen!
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence....
Neurocritical Care guru Dr. Evie Marcolini is back to review recent literature and practice changes in the management of patients with acute ischemic stroke. ...
Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life-threatening hyperglycemic emergency that has a mortality that can be 10 times as high compared with patients...